Here, we use pHLA dextramers to analyze the antigen-specific CD8+ T cells in patients with severe COVID-19 during the acute and convalescent phases, and to determine their phenotype and functionality after in vitro stimulation using flow cytometry and ICS [26,27]. The gene discussed is CD8A; the disease is COVID-19.